GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sailong Pharmaceutical Group Co Ltd (SZSE:002898) » Definitions » Price-to-Operating-Cash-Flow

Sailong Pharmaceutical Group Co (SZSE:002898) Price-to-Operating-Cash-Flow : (As of Jun. 05, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Sailong Pharmaceutical Group Co Price-to-Operating-Cash-Flow?

As of today (2025-06-05), Sailong Pharmaceutical Group Co's share price is ¥12.34. Sailong Pharmaceutical Group Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.19. Hence, Sailong Pharmaceutical Group Co's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Sailong Pharmaceutical Group Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 12 years, Sailong Pharmaceutical Group Co's highest Price-to-Operating-Cash-Flow Ratio was 9360.00. The lowest was 23.79. And the median was 107.66.

SZSE:002898's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 23.99
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Sailong Pharmaceutical Group Co's Cash Flow from Operations per share for the three months ended in Mar. 2025 was ¥-0.07. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.19.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sailong Pharmaceutical Group Co was -242.60% per year.

During the past 12 years, Sailong Pharmaceutical Group Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 487.70% per year. The lowest was -88.10% per year. And the median was 7.00% per year.


Sailong Pharmaceutical Group Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Sailong Pharmaceutical Group Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sailong Pharmaceutical Group Co Price-to-Operating-Cash-Flow Chart

Sailong Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,360.00 51.99 151.88 68.82 -

Sailong Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.28 - 1,528.57 - -

Competitive Comparison of Sailong Pharmaceutical Group Co's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Sailong Pharmaceutical Group Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sailong Pharmaceutical Group Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sailong Pharmaceutical Group Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sailong Pharmaceutical Group Co's Price-to-Operating-Cash-Flow falls into.


;
;

Sailong Pharmaceutical Group Co Price-to-Operating-Cash-Flow Calculation

Sailong Pharmaceutical Group Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=12.34/-0.194
=

Sailong Pharmaceutical Group Co's Share Price of today is ¥12.34.
Sailong Pharmaceutical Group Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.19.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Sailong Pharmaceutical Group Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sailong Pharmaceutical Group Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Sailong Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 47, Haibin South Road, 2nd Floor, Everbright International Trade Center, Guangdong Province, Zhuhai, CHN, 519015
Sailong Pharmaceutical Group Co Ltd is a pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.
Executives
Tang Lin Director
Long Zhi Xiang Director
Deng Yong Jun Supervisors
Zhou Bei Supervisors
Li Jian Feng Directors, executives

Sailong Pharmaceutical Group Co Headlines

No Headlines